{"id":27708,"date":"2021-11-30T09:24:40","date_gmt":"2021-11-30T08:24:40","guid":{"rendered":"https:\/\/kymos.com\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/"},"modified":"2021-11-30T09:24:40","modified_gmt":"2021-11-30T08:24:40","slug":"kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa","status":"publish","type":"post","link":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/","title":{"rendered":"Kymos e ISGlobal uniscono gli sforzi per FERMARE le malattie parassitarie in Africa"},"content":{"rendered":"<p><span style=\"font-size: 14pt;\">&#8220;Kymos \u00e8 un gruppo con i pi\u00f9 elevati standard etici. Questa non \u00e8 una dichiarazione di marketing, ma la nostra filosofia quotidiana&#8221;, sottolinea il Dott. Carles Celma, Direttore Scientifico di Kymos. &#8220;\u00c8 stato un piacere per noi partecipare attivamente al progetto STOP per il trattamento dei parassiti intestinali nei paesi in via di sviluppo non appena ISGlobal ci ha contattato&#8221;.  <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Il Barcelona Institute for Global Health (ISGlobal) \u00e8 un partenariato pubblico-privato che si propone di contribuire ad alleviare le disparit\u00e0 sanitarie tra le regioni del mondo. L&#8217;istituto guida progetti come STOP (Stopping Transmission in Intestinal Parasites), finanziato dall&#8217;EDCTP, per la sperimentazione di una nuova coformulazione farmacologica contro le malattie parassitarie. Il Dott. Jos\u00e9 Mu\u00f1oz, Principal Investigator, spiega l&#8217;ambito del progetto STOP:  <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">&#8220;I vermi parassiti vivono nell&#8217;intestino di fino a un quinto della popolazione mondiale e sono una delle principali cause di malnutrizione, disturbi della crescita e anemia nei bambini&#8221;, inizia il Dott. Mu\u00f1oz. &#8220;Gli attuali trattamenti sono inefficaci contro tricocefali e ossiuri e l&#8217;Organizzazione Mondiale della Sanit\u00e0 ha raccomandato l&#8217;implementazione urgente di ivermectina e albendazolo come alternativa promettente. Il nostro piano \u00e8 di arruolare e trattare 1223 bambini in studi clinici condotti in Kenya, Mozambico ed Etiopia, tre paesi africani con una prevalenza da moderata ad alta di queste malattie causate da vermi parassiti&#8221;.  <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Ma per quanto entusiasmante possa essere un progetto del genere, non \u00e8 stato privo di sfide. Carles Celma ricorda i problemi iniziali che hanno dovuto affrontare: &#8220;ISGlobal ci ha chiesto aiuto per quantificare ivermectina e albendazolo negli studi clinici di Fase II-III in circostanze piuttosto eccezionali: per evitare un&#8217;interruzione della catena del freddo durante la raccolta dei campioni nei tre siti clinici, \u00e8 stato necessario utilizzare le clamshell MITRA Microsampling, una tecnologia che richiede lo sviluppo di metodi analitici esperti e sono orgoglioso di dire che siamo riusciti a supportare ISGlobal nel miglior modo possibile&#8221;, conclude con soddisfazione il Dott. Celma. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Jose Mu\u00f1oz aggiunge ai commenti di Carles Celma: &#8220;Siamo molto soddisfatti di Kymos. Infatti, \u00e8 stato lo stesso produttore di ivermectina e albendazolo a consigliarci di affidare a Kymos la parte analitica del nostro progetto: Jaime Algorta di Exeltis vanta una lunga e proficua esperienza con Kymos e ha espresso (cito) un grande interesse per la loro partecipazione, data la loro affidabilit\u00e0&#8221;.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Il Dott. Celma conclude l&#8217;intervista con un tono diverso: &#8220;Siamo naturalmente felici di ricevere questo tipo di riconoscimento per il nostro lavoro, ma sapere che attraverso il nostro contributo stiamo combattendo l&#8217;infestazione da vermi, contribuendo a spezzare il ciclo della povert\u00e0 e permettendo a questi bambini di andare a scuola e sostenere le loro famiglie \u00e8 ci\u00f2 che rende la nostra collaborazione con ISGlobal davvero eccezionale. \u00c8 cos\u00ec che sappiamo di essere nel business giusto&#8221;, conclude.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-size: 14pt;\">L&#8217;Istituto di Barcellona per la Salute Globale, ISGlobal, \u00e8 il frutto di un&#8217;alleanza innovativa tra la Fondazione &#8220;la Caixa&#8221;, istituzioni accademiche ed enti governativi per contribuire agli sforzi intrapresi dalla comunit\u00e0 internazionale per affrontare le sfide della salute globale. Clicca per saperne di pi\u00f9 su <a href=\"https:\/\/www.isglobal.org\/en\" data-wpel-link=\"external\"><strong>ISGlobal<\/strong><\/a> o sul progetto <a href=\"https:\/\/stoptheworm.org\/\" data-wpel-link=\"external\"><strong>STOP<\/strong><\/a> o contattaci all&#8217;indirizzo <a href=\"mailto:info@isglobal.org?subject=Kymos%20and%20ISGlobal%20join%20efforts%20to%20STOP%20parasitic%20diseases%20in%20Africa\" data-wpel-link=\"internal\"><strong>info@isglobal.org<\/strong><\/a> . <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Kymos \u00e8 un gruppo con i pi\u00f9 elevati standard etici.  [&#8230;]<\/p>\n","protected":false},"author":6,"featured_media":27711,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[263,255],"tags":[62],"class_list":["post-27708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gruppo-kymos","category-notizia","tag-joan"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fermare le malattie parassitarie in Africa | Kymos Group<\/title>\n<meta name=\"description\" content=\"Kymos, una CRO per servizi bioanalitici e CMC per piccole molecole, prodotti biologici e acidi nucleici, supporta ISGlobal nel progetto STOP.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fermare le malattie parassitarie in Africa | Kymos Group\" \/>\n<meta property=\"og:description\" content=\"Kymos, una CRO per servizi bioanalitici e CMC per piccole molecole, prodotti biologici e acidi nucleici, supporta ISGlobal nel progetto STOP.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/\" \/>\n<meta property=\"og:site_name\" content=\"Kymos\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-30T08:24:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1456\" \/>\n\t<meta property=\"og:image:height\" content=\"806\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Joan Puig de Dou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:site\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joan Puig de Dou\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/\"},\"author\":{\"name\":\"Joan Puig de Dou\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"headline\":\"Kymos e ISGlobal uniscono gli sforzi per FERMARE le malattie parassitarie in Africa\",\"datePublished\":\"2021-11-30T08:24:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/\"},\"wordCount\":526,\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/21-11-25_STOP_Newsletter_Banner_short_small.png\",\"keywords\":[\"joan\"],\"articleSection\":[\"Gruppo Kymos\",\"Notizia\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/\",\"url\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/\",\"name\":\"Fermare le malattie parassitarie in Africa | Kymos Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/21-11-25_STOP_Newsletter_Banner_short_small.png\",\"datePublished\":\"2021-11-30T08:24:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"description\":\"Kymos, una CRO per servizi bioanalitici e CMC per piccole molecole, prodotti biologici e acidi nucleici, supporta ISGlobal nel progetto STOP.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/21-11-25_STOP_Newsletter_Banner_short_small.png\",\"contentUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/21-11-25_STOP_Newsletter_Banner_short_small.png\",\"width\":1456,\"height\":806,\"caption\":\"IS Global STOP\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kymos.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kymos e ISGlobal uniscono gli sforzi per FERMARE le malattie parassitarie in Africa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/kymos.com\\\/it\\\/\",\"name\":\"Kymos Group\",\"description\":\"Kymos Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kymos.com\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\",\"name\":\"Joan Puig de Dou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"caption\":\"Joan Puig de Dou\"},\"description\":\"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.\",\"url\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/author\\\/joan-puig-de-dou\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fermare le malattie parassitarie in Africa | Kymos Group","description":"Kymos, una CRO per servizi bioanalitici e CMC per piccole molecole, prodotti biologici e acidi nucleici, supporta ISGlobal nel progetto STOP.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/","og_locale":"it_IT","og_type":"article","og_title":"Fermare le malattie parassitarie in Africa | Kymos Group","og_description":"Kymos, una CRO per servizi bioanalitici e CMC per piccole molecole, prodotti biologici e acidi nucleici, supporta ISGlobal nel progetto STOP.","og_url":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/","og_site_name":"Kymos","article_published_time":"2021-11-30T08:24:40+00:00","og_image":[{"width":1456,"height":806,"url":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","type":"image\/png"}],"author":"Joan Puig de Dou","twitter_card":"summary_large_image","twitter_creator":"@KymosGroup","twitter_site":"@KymosGroup","twitter_misc":{"Scritto da":"Joan Puig de Dou","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/#article","isPartOf":{"@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/"},"author":{"name":"Joan Puig de Dou","@id":"https:\/\/kymos.com\/it\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"headline":"Kymos e ISGlobal uniscono gli sforzi per FERMARE le malattie parassitarie in Africa","datePublished":"2021-11-30T08:24:40+00:00","mainEntityOfPage":{"@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/"},"wordCount":526,"image":{"@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","keywords":["joan"],"articleSection":["Gruppo Kymos","Notizia"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/","url":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/","name":"Fermare le malattie parassitarie in Africa | Kymos Group","isPartOf":{"@id":"https:\/\/kymos.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/#primaryimage"},"image":{"@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","datePublished":"2021-11-30T08:24:40+00:00","author":{"@id":"https:\/\/kymos.com\/it\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"description":"Kymos, una CRO per servizi bioanalitici e CMC per piccole molecole, prodotti biologici e acidi nucleici, supporta ISGlobal nel progetto STOP.","breadcrumb":{"@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/#primaryimage","url":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","contentUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","width":1456,"height":806,"caption":"IS Global STOP"},{"@type":"BreadcrumbList","@id":"https:\/\/kymos.com\/it\/news\/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kymos.com\/it\/"},{"@type":"ListItem","position":2,"name":"Kymos e ISGlobal uniscono gli sforzi per FERMARE le malattie parassitarie in Africa"}]},{"@type":"WebSite","@id":"https:\/\/kymos.com\/it\/#website","url":"https:\/\/kymos.com\/it\/","name":"Kymos Group","description":"Kymos Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kymos.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/kymos.com\/it\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c","name":"Joan Puig de Dou","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","caption":"Joan Puig de Dou"},"description":"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.","url":"https:\/\/kymos.com\/it\/news\/author\/joan-puig-de-dou\/"}]}},"_links":{"self":[{"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/posts\/27708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/comments?post=27708"}],"version-history":[{"count":0,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/posts\/27708\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/media\/27711"}],"wp:attachment":[{"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/media?parent=27708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/categories?post=27708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/tags?post=27708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}